文献速递免疫规划慢病防控与筛查

生命早期接种疫苗与1型糖尿病高危儿童胰岛自身免疫发展无关:前瞻性队列数据结果

Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data.
PubMed 文献 · Vaccine · 2017-03-03

研究基于1918名高危儿童共20570份接种记录,采用Cox回归分析生命早期疫苗接种与1型糖尿病相关胰岛自身免疫的关联,并利用295420人的索赔数据验证蜱传脑炎疫苗关联。多数疫苗未显著增加自身免疫风险,蜱传脑炎疫苗在验证队列中未证实与1型糖尿病相关,结论认为早期接种不增加胰岛自身免疫风险。

要点

  • 多数疫苗接种与胰岛自身免疫风险无显著关联,如0-24月龄每增加一剂麻腮风疫苗的HR为1.08(95%CI 0.96-1.21)。
  • 0-24月龄每增加一剂蜱传脑炎疫苗与自身免疫风险名义显著升高相关(HR 1.44,95%CI 1.06-1.96),但验证队列中与1型糖尿病无关(HR 1.02,95%CI 0.90-1.16)。
  • 结论认为无证据表明早期接种增加1型糖尿病相关胰岛自身免疫风险,蜱传脑炎疫苗的潜在关联可能为假阳性。

核心结论

  • 未发现早期接种疫苗增加1型糖尿病相关胰岛自身免疫风险的证据。
  • 早期蜱传脑炎疫苗接种的潜在关联未能在独立队列中证实,看似为假阳性发现。

研究设计与样本

  • 前瞻性队列研究,纳入1918名高危儿童,分析20570份认证接种记录与胰岛自身免疫发生时间的关联。
  • 采用Cox回归,考虑至2岁前的多个时间段和疫苗类型,并调整HLA基因型、性别、分娩方式、出生季节、早产和母亲1型糖尿病状态。
  • 另用295420名受试者的前瞻性索赔数据验证蜱传脑炎疫苗接种的关联。

主要发现

  • 多数疫苗接种与胰岛自身免疫风险无显著关联,例如0-24月龄每增加一剂麻腮风疫苗的HR为1.08(95%CI 0.96-1.21)。
  • 0-24月龄每增加一剂蜱传脑炎疫苗与自身免疫风险名义显著升高相关(HR 1.44,95%CI 1.06-1.96)。
  • 验证队列中蜱传脑炎疫苗与1型糖尿病风险无显著关联(HR 1.02,95%CI 0.90-1.16)。

关键数值与推荐

  • 0-24月龄每增加一剂麻腮风疫苗的HR为1.08(95%CI 0.96-1.21)。
  • 0-24月龄每增加一剂蜱传脑炎疫苗的HR为1.44(95%CI 1.06-1.96)。
  • 验证队列中0-24月龄每增加一剂蜱传脑炎疫苗与1型糖尿病的HR为1.02(95%CI 0.90-1.16)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 蜱传脑炎疫苗与自身免疫风险的关联仅为名义显著,且未能在独立验证队列中证实,原文认为看似为假阳性发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Vaccinations in early childhood potentially stimulate the immune system and may thus be relevant for the pathogenesis of autoimmune diseases such as type 1 diabetes (T1D). We determined the association of vaccination burden with T1D-associated islet autoimmunity in children with high familial risk followed prospectively from birth. METHODS: A total of 20,570 certified vaccination records from 1918 children were correlated with time to onset of T1D-associated islet autoimmunity using Cox regression, considering multiple time periods up until age two years and vaccination types, and adjusting for HLA genotype, sex, delivery mode, season of birth, preterm delivery and maternal T1D status. Additionally, prospective claims data of 295,420 subjects were used to validate associations for the tick-borne encephalitis (TBE) vaccination. RESULTS: Most vaccinations were not associated with a significantly increased hazard ratio (HR) for islet autoimmunity (e.g. HR [95% confidence interval]: 1.08 [0.96-1.21] per additional vaccination against measles, mumps and rubella at age 0-24months). TBE vaccinations within the first two years of life were nominally associated with a significantly increased autoimmunity risk (HR: 1.44 [1.06-1.96] per additional vaccination at age 0-24months), but this could not be confirmed with respect to outcome T1D in the validation cohort (HR: 1.02 [0.90-1.16]). CONCLUSIONS: We found no evidence that early vaccinations increase the risk of T1D-associated islet autoimmunity development. The potential association with early TBE vaccinations could not be confirmed in an independent cohort and appears to be a false positive finding.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Beyerlein A, Strobl AN, Winkler C, et al. Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data. Vaccine. 2017. PMID: 28268073. doi:10.1016/j.vaccine.2017.02.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。